Startup · Fort Lauderdale
ILiAD Biotechnologies
Clinical-stage biotechnology company developing vaccines and therapeutics targeting Bordetella pertussis, the bacterium that causes whooping cough.
HealthTechBiotech & Life SciencesGrowth / Scaling
Clinical-stage biotech startup focused on pertussis (whooping cough) prevention and treatment.
Notable: Raised a $115M Series B in February 2026 to advance its pertussis vaccine program.